Hu Wei, Varma Madhulika G, Huang Xiaoli, Wang Xin, Shang Ke, Xu Di, Li Xia
First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
Front Med (Lausanne). 2025 Jun 23;12:1602198. doi: 10.3389/fmed.2025.1602198. eCollection 2025.
Assessing the severity of constipation in patients is important for tailoring treatment plans and monitoring outcomes. However, validated assessment tools for constipation severity are limited in China.
This study aimed to evaluate the psychometric properties of the Chinese version of the Constipation Severity Index (CSI).
A cross-sectional survey was conducted in two tertiary hospitals in China. A total of 621 patients meeting the diagnostic criteria for constipation were enrolled. The scale's reliability and validity were assessed using Content Validity Index (CVI), Exploratory Factor Analysis (EFA), Confirmatory Factor Analysis (CFA), internal consistency, and test-retest reliability.
The expert-rated Item-level Content Validity Index (I-CVI) was 0.90. EFA revealed a three-factor structure comprising 16 items, accounting for 71.81% of the total variance. CFA results suggested acceptable model fit (χ2 = 257.711, df = 96, < 0.001; CFI = 0.965; TLI = 0.956; RMSEA = 0.074, 90% CI: 0.063-0.085; SRMR = 0.047). The scale demonstrated good internal consistency (Cronbach's alpha = 0.936, McDonald's Omega = 0.937).
This study provides preliminary evidence for the reliability and validity of the Chinese version of the CSI. While the initial results are promising, further research is needed to validate its applicability in various clinical settings and patient populations. The CSI may potentially serve as a useful tool for assessing constipation severity in Chinese patients, but additional validation studies are necessary before its widespread clinical application.
评估患者便秘的严重程度对于制定治疗方案和监测治疗效果至关重要。然而,在中国,用于评估便秘严重程度的经过验证的评估工具有限。
本研究旨在评估中文版便秘严重程度指数(CSI)的心理测量特性。
在中国的两家三级医院进行了一项横断面调查。共纳入621例符合便秘诊断标准的患者。使用内容效度指数(CVI)、探索性因素分析(EFA)、验证性因素分析(CFA)、内部一致性和重测信度来评估该量表的信度和效度。
专家评定的条目水平内容效度指数(I-CVI)为0.90。EFA显示出一个由16个条目组成的三因素结构,占总方差的71.81%。CFA结果表明模型拟合可接受(χ2 = 257.711,df = 96,<0.001;CFI = 0.965;TLI = 0.956;RMSEA = 0.074,90% CI:0.063 - 0.085;SRMR = 0.047)。该量表显示出良好的内部一致性(Cronbach's alpha = 0.936,McDonald's Omega = 0.937)。
本研究为中文版CSI的信度和效度提供了初步证据。虽然初步结果很有前景,但需要进一步研究来验证其在各种临床环境和患者群体中的适用性。CSI可能是评估中国患者便秘严重程度的有用工具,但在广泛临床应用之前还需要更多的验证研究。